Thomas Jefferson University

Claresa Levetan

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentCommencement - Thomas Jefferson University
Address1025 Walnut Street
Philadelphia PA 19107
Phone2159559555
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Levetan C. Frederick Banting's observations leading to the potential for islet neogenesis without transplantation. J Diabetes. 2022 Feb; 14(2):104-110. PMID: 34967992.
      Citations:    
    2. Levetan C, Pozzilli P, Jovanovic L, Schatz D. Proposal for generating new beta cells in a muted immune environment for type 1 diabetes. Diabetes Metab Res Rev. 2013 Nov; 29(8):604-6. PMID: 23853103.
      Citations:    
    3. Levetan CS, Pierce SM. Distinctions between the islets of mice and men: implications for new therapies for type 1 and 2 diabetes. Endocr Pract. 2013 Mar-Apr; 19(2):301-12. PMID: 23186955.
      Citations:    
    4. Levetan C. Distinctions between islet neogenesis and ?-cell replication: implications for reversal of Type 1 and 2 diabetes. J Diabetes. 2010 Jun; 2(2):76-84. PMID: 20923488.
      Citations:    
    5. Levetan CS, Upham LV, Deng S, Laury-Kleintop L, Kery V, Nolan R, Quinlan J, Torres C, El-Hajj RJ. Discovery of a human peptide sequence signaling islet neogenesis. Endocr Pract. 2008 Dec; 14(9):1075-83. PMID: 19158046.
      Citations:    
    6. Levetan C. Oral antidiabetic agents in type 2 diabetes. Curr Med Res Opin. 2007 Apr; 23(4):945-52. PMID: 17407651.
      Citations:    
    7. Levetan CS, Dawn KR, Murray JF, Popma JJ, Ratner RE, Robbins DC. Impact of computer-generated personalized goals on cholesterol lowering. Value Health. 2005 Nov-Dec; 8(6):639-46. PMID: 16283864.
      Citations:    
    8. Tanenberg R, Bode B, Lane W, Levetan C, Mestman J, Harmel AP, Tobian J, Gross T, Mastrototaro J. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc. 2004 Dec; 79(12):1521-6. PMID: 15595336.
      Citations:    
    9. LeRoith D, Levetan CS, Hirsch IB, Riddle MC. Type 2 diabetes: the role of basal insulin therapy. J Fam Pract. 2004 Mar; 53(3):215-22. PMID: 15000929.
      Citations:    
    10. Levetan CS. Effect of hyperglycemia on stroke outcomes. Endocr Pract. 2004 Mar-Apr; 10 Suppl 2:34-9. PMID: 15251638.
      Citations:    
    11. Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman OG, Chandran M, Mudaliar SR, Henry RR. Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps. Diabetes Care. 2003 Jan; 26(1):1-8. PMID: 12502651.
      Citations:    
    12. Levetan CS, Dawn KR, Robbins DC, Ratner RE. Impact of computer-generated personalized goals on HbA(1c). Diabetes Care. 2002 Jan; 25(1):2-8. PMID: 11772893.
      Citations:    
    13. Levetan CS. Hemoglobin A1c: need to standardize the term. Endocr Pract. 2002; 8 Suppl 1:25-6. PMID: 15251847.
      Citations:    
    14. Stathatos N, Levetan C, Burman KD, Wartofsky L. The controversy of the treatment of critically ill patients with thyroid hormone. Best Pract Res Clin Endocrinol Metab. 2001 Dec; 15(4):465-78. PMID: 11800518.
      Citations:    
    15. Levetan CS, Magee MF. Hospital management of diabetes. Endocrinol Metab Clin North Am. 2000 Dec; 29(4):745-70. PMID: 11149160.
      Citations:    
    16. Levetan CS, Passaro MD, Jablonski KA, Ratner RE. Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care. 1999 Nov; 22(11):1790-5. PMID: 10546009.
      Citations:    
    17. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE. Unrecognized diabetes among hospitalized patients. Diabetes Care. 1998 Feb; 21(2):246-9. PMID: 9539990.
      Citations:    
    18. Levetan CS, Salas JR, Wilets IF, Zumoff B. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995 Jul; 99(1):22-8. PMID: 7598138.
      Citations:    
    19. Levetan C, Wartofsky L. A clinical guide to the management of Graves' disease with radioactive iodine. Endocr Pract. 1995 May-Jun; 1(3):205-12. PMID: 15251595.
      Citations:    
    Levetan's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (144)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (59)
    Explore
    _